Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Flavors & Fragrances
IFF
|
+$102M |
| 2 |
Plug Power
PLUG
|
+$90.4M |
| 3 |
Microsoft
MSFT
|
+$82.2M |
| 4 |
Roku
ROKU
|
+$80.7M |
| 5 |
CrowdStrike
CRWD
|
+$79.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$296M |
| 2 |
Alibaba
BABA
|
+$263M |
| 3 |
TIF
Tiffany & Co.
TIF
|
+$148M |
| 4 |
Amazon
AMZN
|
+$113M |
| 5 |
DuPont de Nemours
DD
|
+$93.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.15% |
| 2 | Financials | 13.54% |
| 3 | Healthcare | 12.15% |
| 4 | Consumer Discretionary | 11.82% |
| 5 | Communication Services | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
2301
DELISTED
Revance Therapeutics, Inc.
RVNC
| $510K | ﹤0.01% |
18,254
+1,164
| +7% | +$32.2K |
|
2302
BioCryst Pharmaceuticals
BCRX
$2.4B
| $504K | ﹤0.01% |
49,572
-2,011
| -4% | -$20.7K |
|
2303
Spok Holdings
SPOK
$241M
| $502K | ﹤0.01% |
47,890
-1,222
| -2% | -$14K |
|
|
SRNE
2304
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $500K | ﹤0.01% |
60,363
-1,962
| -3% | -$20.7K |
|
2305
Liberty Latin America Class A
LILA
$1.67B
| $498K | ﹤0.01% |
57,114
-1,279
| -2% | -$10.5K |
|
2306
Alphatec Holdings
ATEC
$1.44B
| $495K | ﹤0.01% |
31,387
-217
| -0.7% | -$3.42K |
|
|
AMRS
2307
DELISTED
Amyris Inc.
AMRS
| $487K | ﹤0.01% |
25,472
+10,192
| +67% | +$148K |
|
|
CMRC
2308
Commerce.com Inc Series 1
CMRC
$184M
| $484K | ﹤0.01% |
8,376
+6,218
| +288% | +$413K |
|
|
LCI
2309
DELISTED
Lannett Company, Inc.
LCI
| $484K | ﹤0.01% |
22,918
-619
| -3% | -$16.3K |
|
|
CWEN.A
2310
DELISTED
Clearway Energy Class A
CWEN.A
| $481K | ﹤0.01% |
18,133
+1,092
| +6% | +$31.5K |
|
|
ARD
2311
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $466K | ﹤0.01% |
18,299
+160
| +0.9% | +$3.44K |
|
2312
iShares Core S&P 500 ETF
IVV
$902B
| $465K | ﹤0.01% |
1,170
-500
| -30% | -$194K |
|
|
ORTX
2313
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $463K | ﹤0.01% |
6,387
+670
| +12% | +$47.6K |
|
|
KNL
2314
DELISTED
Knoll, Inc.
KNL
| $463K | ﹤0.01% |
28,093
+684
| +2% | +$11.2K |
|
|
ZUO
2315
DELISTED
Zuora, Inc.
ZUO
| $462K | ﹤0.01% |
31,234
+1,416
| +5% | +$21.1K |
|
2316
PLDT
PHI
$4.33B
| $461K | ﹤0.01% |
17,615
| – | – |
|
2317
SFL Corp
SFL
$1.61B
| $461K | ﹤0.01% |
57,502
-22,558
| -28% | -$167K |
|
2318
Acco Brands
ACCO
$407M
| $452K | ﹤0.01% |
53,576
+1,267
| +2% | +$10.9K |
|
2319
Scorpio Tankers
STNG
$3.81B
| $451K | ﹤0.01% |
24,424
-703
| -3% | -$10.9K |
|
2320
CryoPort
CYRX
$762M
| $448K | ﹤0.01% |
8,597
+262
| +3% | +$15.9K |
|
|
GTM
2321
ZoomInfo Technologies
GTM
$1.22B
| $447K | ﹤0.01% |
9,145
+6,560
| +254% | +$330K |
|
2322
Columbia Financial
CLBK
$1.13B
| $444K | ﹤0.01% |
25,387
+23
| +0.1% | +$382 |
|
2323
Banco de Chile
BCH
$20.9B
| $443K | ﹤0.01% |
18,725
+1,966
| +12% | +$44.1K |
|
2324
Calix
CALX
$2.39B
| $439K | ﹤0.01% |
12,673
+84
| +0.7% | +$3.11K |
|
|
AXNX
2325
DELISTED
Axonics, Inc. Common Stock
AXNX
| $428K | ﹤0.01% |
7,152
-265
| -4% | -$14.4K |
|
Similar funds
Legal & General Group's Q1 2021 Portfolio in Review
As of Q1 2021, Legal & General Group held 3,553 positions worth $268B, up 5.1% from $255B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 3.1%. Legal & General Group opened 74 new positions and exited 35, leaving the 3,553-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q1 2021 buy was Allot: 1,695,694 shares worth $27.1M.
- Legal & General Group added most to International Flavors & Fragrances in Q1 2021, an estimated $102M increase.
- Legal & General Group's biggest Q1 2021 reduction was Apple, cutting an estimated $296M.
- Legal & General Group fully exited Tiffany & Co. in Q1 2021, selling an estimated $148M.
- Legal & General Group's ten largest holdings make up 20% of its $268B portfolio in Q1 2021.
- Legal & General Group opened 74 new positions and closed 35 in Q1 2021.
- Legal & General Group's portfolio value rose 5.1% quarter-over-quarter to $268B.
Based on Legal & General Group's 13F filing for Q1 2021, filed 17 May 2021.